Qingbin Liu

机构：Jilin Normal University, Jilin Engineering Normal University · ORCID：0009-0005-0157-924X

发表论文 31 篇 · 总被引 375 次 · h-index 11

代表论文

• Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC (2024 · Hepatology · 被引 65)
• Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights (2022 · Frontiers in Pharmacology · 被引 53)
• A comparative study on effects of dietary three strains of lactic acid bacteria on the growth performance, immune responses, disease resistance and intestinal microbiota of Pacific white shrimp, Penaeus vannamei (2023 · Fish & Shellfish Immunology · 被引 38)
• Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma (2025 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway (2023 · Journal of Ethnopharmacology · 被引 22)
• Therapeutic effect and transcriptome-methylome characteristics of METTL3 inhibition in liver hepatocellular carcinoma (2023 · Cancer Cell International · 被引 15)